Observational studyJournal of translational medicine2025

Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed/refractory multiple myeloma.

Ning An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.